Extracellular vesicles as drug delivery systems: Lessons from the liposome field

Journal of Controlled Release

Volumn 195, Issue , 2014, Pages 72-85

  Van Der Meel, Roy ^a   Fens, Marcel H A M ^a   Vader, Pieter ^a,b   Van Solinge, Wouter W ^a   Eniola Adefeso, Omolola ^c   Schiffelers, Raymond M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CONTROLLED DRUG DELIVERY; COST EFFECTIVENESS; CYTOLOGY; DRUG INTERACTIONS; LIPID BILAYERS; LIPOSOMES;

BIODISTRIBUTIONS; CELLULAR INTERACTION; CIRCULATION TIME; DELIVERY SYSTEMS; DRUG DELIVERY SYSTEM; INTERCELLULAR COMMUNICATIONS; LARGE SCALE PRODUCTIONS; THERAPEUTIC DRUG DELIVERY;

TARGETED DRUG DELIVERY;

LIPID NANOPARTICLE; LIPOSOME; NANOPARTICLE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL INTERACTION; CIRCULATION TIME; EXTRACELLULAR VESICLE; HUMAN; KINETICS; LIPOSOMAL DELIVERY; MEMBRANE VESICLE; MICROFLUIDICS; MOLECULE; NANOMEDICINE; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); ANIMAL; DRUG DELIVERY SYSTEM; MEMBRANE MICROPARTICLE;

ANIMALS; CELL-DERIVED MICROPARTICLES; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES;

EID: 84908571833     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.07.049     Document Type: Review

References (167)

1. R. Duncan, and R. Gaspar Nanomedicine(s) under the microscope Mol. Pharm. 8 2011 2101 2141
2. M.L. Etheridge, S.A. Campbell, A.G. Erdman, C.L. Haynes, S.M. Wolf, and J. McCullough The big picture on nanomedicine: the state of investigational and approved nanomedicine products Nanomedicine 9 2013 1 14
3. S. Svenson Clinical translation of nanomedicines Curr. Opin. Solid State Mater. Sci. 16 2012 287 294
4. V.P. Chauhan, and R.K. Jain Strategies for advancing cancer nanomedicine Nat. Mater. 12 2013 958 962
5. J.W. Yoo, D.J. Irvine, D.E. Discher, and S. Mitragotri Bio-inspired, bioengineered and biomimetic drug delivery carriers Nat. Rev. Drug Discov. 10 2011 521 535
6. S. El Andaloussi, I. Mäger, X.O. Breakefield, and M.J. Wood Extracellular vesicles: biology and emerging therapeutic opportunities Nat. Rev. Drug Discov. 12 2013 347 357
7. P. Vader, X.O. Breakefield, and M.J. Wood Extracellular vesicles: emerging targets for cancer therapy Trends Mol. Med. 20 2014 385 393
8. R. van der Meel, M. Krawczyk-Durka, W.W. van Solinge, and R.M. Schiffelers Toward routine detection of extracellular vesicles in clinical samples Int. J. Lab. Hematol. 36 2014 244 253
9. E. van der Pol, A.N. Boing, P. Harrison, A. Sturk, and R. Nieuwland Classification, functions, and clinical relevance of extracellular vesicles Pharmacol. Rev. 64 2012 676 705
10. J. Kranich, N.J. Krautler, E. Heinen, M. Polymenidou, C. Bridel, A. Schildknecht, C. Huber, M.H. Kosco-Vilbois, R. Zinkernagel, G. Miele, and A. Aguzzi Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8 J. Exp. Med. 205 2008 1293 1302
11. G. Raposo, and W. Stoorvogel Extracellular vesicles: exosomes, microvesicles, and friends J. Cell Biol. 200 2013 373 383
12. S.M. van Dommelen, P. Vader, S. Lakhal, S.A. Kooijmans, W.W. van Solinge, M.J. Wood, and R.M. Schiffelers Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery J. Control. Release 161 2012 635 644
13. S.A. Kooijmans, P. Vader, S.M. van Dommelen, W.W. van Solinge, and R.M. Schiffelers Exosome mimetics: a novel class of drug delivery systems Int. J. Nanomedicine 7 2012 1525 1541
14. G. Gregoriadis, and B.E. Ryman Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases Biochem. J. 124 1971 58P
15. T.M. Allen, and P.R. Cullis Liposomal drug delivery systems: from concept to clinical applications Adv. Drug Deliv. Rev. 65 2013 36 48
16. S.C. Jang, O.Y. Kim, C.M. Yoon, D.S. Choi, T.Y. Roh, J. Park, J. Nilsson, J. Lotvall, Y.K. Kim, and Y.S. Gho Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors ACS Nano 7 2013 7698 7710
17. A. Waldenstrom, N. Genneback, U. Hellman, and G. Ronquist Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells PLoS One 7 2012 e34653
18. C. Thery, S. Amigorena, G. Raposo, and A. Clayton Isolation and characterization of exosomes from cell culture supernatants and biological fluids Curr. Protoc. Cell Biol. 2006 22 (Chapter 3, Unit 3 22)
19. F. Arslan, R.C. Lai, M.B. Smeets, L. Akeroyd, A. Choo, E.N. Aguor, L. Timmers, H.V. van Rijen, P.A. Doevendans, G. Pasterkamp, S.K. Lim, and D.P. de Kleijn Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury Stem Cell Res. 10 2013 301 312
20. R.C. Lai, F. Arslan, M.M. Lee, N.S. Sze, A. Choo, T.S. Chen, M. Salto-Tellez, L. Timmers, C.N. Lee, R.M. El Oakley, G. Pasterkamp, D.P. de Kleijn, and S.K. Lim Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury Stem Cell Res. 4 2010 214 222
21. Z. Varga, Y. Yuana, A.E. Grootemaat, E. van der Pol, C. Gollwitzer, M. Krumrey, and R. Nieuwland Towards traceable size determination of extracellular vesicles J. Extracell. Vesicles 3 2014
22. J.L. Hood, R.S. San, and S.A. Wickline Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis Cancer Res. 71 2011 3792 3801
23. N. Arraud, R. Linares, S. Tan, C. Gounou, J.M. Pasquet, S. Mornet, and A.R. Brisson Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration J. Thromb. Haemost. 12 2014 614 627
24. D. Sun, X. Zhuang, X. Xiang, Y. Liu, S. Zhang, C. Liu, S. Barnes, W. Grizzle, D. Miller, and H.G. Zhang A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes Mol. Ther. 18 2010 1606 1614
25. C. Gardiner, Y.J. Ferreira, R.A. Dragovic, C.W. Redman, and I.L. Sargent Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis J. Extracell. Vesicles 2 2013
26. J. de Vrij, S.L. Maas, M. van Nispen, M. Sena-Esteves, R.W. Limpens, A.J. Koster, S. Leenstra, M.L. Lamfers, and M.L. Broekman Quantification of nanosized extracellular membrane vesicles with scanning ion occlusion sensing Nanomedicine (Lond.) 8 2013 1443 1458
27. ® EL Nanomedicine (Lond.) 8 2013 1127 1135
28. K. Matsuzaki, O. Murase, K. Sugishita, S. Yoneyama, K. Akada, M. Ueha, A. Nakamura, and S. Kobayashi Optical characterization of liposomes by right angle light scattering and turbidity measurement Biochim. Biophys. Acta 1467 2000 219 226
29. R.E. Mebius, and G. Kraal Structure and function of the spleen Nat. Rev. Immunol. 5 2005 606 616
30. D. Liu, F. Liu, and Y.K. Song Monosialoganglioside GM1 shortens the blood circulation time of liposomes in rats Pharm. Res. 12 1995 508 512
31. R.M. Schiffelers, I.A. Bakker-Woudenberg, S.V. Snijders, and G. Storm Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: influence of liposome characteristics Biochim. Biophys. Acta 1421 1999 329 339
32. R.M. Abra, and C.A. Hunt Liposome disposition in vivo. III. Dose and vesicle-size effects Biochim. Biophys. Acta 666 1981 493 503
33. J. Lievens, J. Snoeys, K. Vekemans, S. Van Linthout, R. de Zanger, D. Collen, E. Wisse, and B. De Geest The size of sinusoidal fenestrae is a critical determinant of hepatocyte transduction after adenoviral gene transfer Gene Ther. 11 2004 1523 1531
34. E.L. Romero, M.J. Morilla, J. Regts, G.A. Koning, and G.L. Scherphof On the mechanism of hepatic transendothelial passage of large liposomes FEBS Lett. 448 1999 193 196
35. E. Wisse, F. Jacobs, B. Topal, P. Frederik, and B. De Geest The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer Gene Ther. 15 2008 1193 1199
36. J.H. Senior Fate and behavior of liposomes in vivo: a review of controlling factors Crit. Rev. Ther. Drug Carrier Syst. 3 1987 123 193
37. D. Papahadjopoulos, and A. Gabizon Liposomes designed to avoid the reticuloendothelial system Prog. Clin. Biol. Res. 343 1990 85 93
38. M.C. Woodle, and D.D. Lasic Sterically stabilized liposomes Biochim. Biophys. Acta 1113 1992 171 199
39. M.C. Woodle, K.K. Matthay, M.S. Newman, J.E. Hidayat, L.R. Collins, C. Redemann, F.J. Martin, and D. Papahadjopoulos Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes Biochim. Biophys. Acta 1105 1992 193 200
40. M.C. Woodle Surface-modified liposomes: assessment and characterization for increased stability and prolonged blood circulation Chem. Phys. Lipids 64 1993 249 262
41. N. Oku, and Y. Namba Long-circulating liposomes Crit. Rev. Ther. Drug Carrier Syst. 11 1994 231 270
42. V.P. Torchilin Affinity liposomes in vivo: factors influencing target accumulation J. Mol. Recognit. 9 1996 335 346
43. A. Gabizon, and D. Papahadjopoulos Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors Proc. Natl. Acad. Sci. U. S. A. 85 1988 6949 6953
44. T.M. Allen, C. Hansen, and J. Rutledge Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues Biochim. Biophys. Acta 981 1989 27 35
45. A.L. Klibanov, K. Maruyama, V.P. Torchilin, and L. Huang Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Lett. 268 1990 235 237
46. J. Senior, C. Delgado, D. Fisher, C. Tilcock, and G. Gregoriadis Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles Biochim. Biophys. Acta 1062 1991 77 82
47. T.M. Allen, C. Hansen, F. Martin, C. Redemann, and A. Yau-Young Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo Biochim. Biophys. Acta 1066 1991 29 36
48. D. Papahadjopoulos, T.M. Allen, A. Gabizon, E. Mayhew, K. Matthay, S.K. Huang, K.D. Lee, M.C. Woodle, D.D. Lasic, and C. Redemann Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy Proc. Natl. Acad. Sci. U. S. A. 88 1991 11460 11464
49. K.J. Wieder, N.C. Palczuk, T. van Es, and F.F. Davis Some properties of polyethylene glycol:phenylalanine ammonia-lyase adducts J. Biol. Chem. 254 1979 12579 12587
50. P.S. Pyatak, A. Abuchowski, and F.F. Davis Preparation of a polyethylene glycol: superoxide dismutase adduct, and an examination of its blood circulation life and anti-inflammatory activity Res. Commun. Chem. Pathol. Pharmacol. 29 1980 113 127
51. A. Gabizon, R. Catane, B. Uziely, B. Kaufman, T. Safra, R. Cohen, F. Martin, A. Huang, and Y. Barenholz Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes Cancer Res. 54 1994 987 992
52. S.K. Huang, E. Mayhew, S. Gilani, D.D. Lasic, F.J. Martin, and D. Papahadjopoulos Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma Cancer Res. 52 1992 6774 6781
53. T.M. Allen, T. Mehra, C. Hansen, and Y.C. Chin Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine Cancer Res. 52 1992 2431 2439
54. R.M. Schiffelers, I.A. Bakker-Woudenberg, and G. Storm Localization of sterically stabilized liposomes in experimental rat Klebsiella pneumoniae pneumonia: dependence on circulation kinetics and presence of poly(ethylene)glycol coating Biochim. Biophys. Acta 1468 2000 253 261
55. P. Charoenphol, P.J. Onyskiw, M. Carrasco-Teja, and O. Eniola-Adefeso Particle-cell dynamics in human blood flow: implications for vascular-targeted drug delivery J. Biomech. 45 2012 2822 2828
56. K. Namdee, A.J. Thompson, P. Charoenphol, and O. Eniola-Adefeso Margination propensity of vascular-targeted spheres from blood flow in a microfluidic model of human microvessels Langmuir 29 2013 2530 2535
57. M.J. Pearson, and H.H. Lipowsky Influence of erythrocyte aggregation on leukocyte margination in postcapillary venules of rat mesentery Am. J. Physiol. Heart Circ. Physiol. 279 2000 H1460 H1471
58. A.J. Thompson, E.M. Mastria, and O. Eniola-Adefeso The margination propensity of ellipsoidal micro/nanoparticles to the endothelium in human blood flow Biomaterials 34 2013 5863 5871
59. P. Charoenphol, S. Mocherla, D. Bouis, K. Namdee, D.J. Pinsky, and O. Eniola-Adefeso Targeting therapeutics to the vascular wall in atherosclerosis - carrier size matters Atherosclerosis 217 2011 364 370
60. T.R. Lee, M. Choi, A.M. Kopacz, S.H. Yun, W.K. Liu, and P. Decuzzi On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better Sci. Rep. 3 2013 2079
61. K. Muller, D.A. Fedosov, and G. Gompper Margination of micro- and nano-particles in blood flow and its effect on drug delivery Sci. Rep. 4 2014 4871
62. H.L. Goldsmith, and S. Spain Margination of leukocytes in blood flow through small tubes Microvasc. Res. 27 1984 204 222
63. J.R. Less, T.C. Skalak, E.M. Sevick, and R.K. Jain Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions Cancer Res. 51 1991 265 273
64. E.M. Sevick, and R.K. Jain Viscous resistance to blood flow in solid tumors: effect of hematocrit on intratumor blood viscosity Cancer Res. 49 1989 3513 3519
65. T.W. Secomb, B. Styp-Rekowska, and A.R. Pries Two-dimensional simulation of red blood cell deformation and lateral migration in microvessels Ann. Biomed. Eng. 35 2007 755 765
66. C.P. Lai, O. Mardini, M. Ericsson, S. Prabhakar, C.A. Maguire, J.W. Chen, B.A. Tannous, and X.O. Breakefield Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter ACS Nano 8 2014 483 494
67. R.F. Zwaal, E.M. Bevers, P. Comfurius, J. Rosing, R.H. Tilly, and P.F. Verhallen Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance Mol. Cell. Biochem. 91 1989 23 31
68. P.D. Robbins, and A.E. Morelli Regulation of immune responses by extracellular vesicles Nat. Rev. Immunol. 14 2014 195 208
69. S. Nagata, R. Hanayama, and K. Kawane Autoimmunity and the clearance of dead cells Cell 140 2010 619 630
70. F.L. Willekens, J.M. Werre, J.K. Kruijt, B. Roerdinkholder-Stoelwinder, Y.A. Groenen-Dopp, A.G. van den Bos, G.J. Bosman, and T.J. van Berkel Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors Blood 105 2005 2141 2145
71. H. Peinado, M. Aleckovic, S. Lavotshkin, I. Matei, B. Costa-Silva, G. Moreno-Bueno, M. Hergueta-Redondo, C. Williams, G. Garcia-Santos, C. Ghajar, A. Nitadori-Hoshino, C. Hoffman, K. Badal, B.A. Garcia, M.K. Callahan, J. Yuan, V.R. Martins, J. Skog, R.N. Kaplan, M.S. Brady, J.D. Wolchok, P.B. Chapman, Y. Kang, J. Bromberg, and D. Lyden Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET Nat. Med. 18 2012 883 891
72. S. Ohno, M. Takanashi, K. Sudo, S. Ueda, A. Ishikawa, N. Matsuyama, K. Fujita, T. Mizutani, T. Ohgi, T. Ochiya, N. Gotoh, and M. Kuroda Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells Mol. Ther. 21 2013 185 191
73. K.N. Sugahara, T. Teesalu, P.P. Karmali, V.R. Kotamraju, L. Agemy, O.M. Girard, D. Hanahan, R.F. Mattrey, and E. Ruoslahti Tissue-penetrating delivery of compounds and nanoparticles into tumors Cancer Cell 16 2009 510 520
74. Y. Tian, S. Li, J. Song, T. Ji, M. Zhu, G.J. Anderson, J. Wei, and G. Nie A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy Biomaterials 35 2014 2383 2390
75. R.M. Schiffelers, G.A. Koning, T.L. ten Hagen, M.H. Fens, A.J. Schraa, A.P. Janssen, R.J. Kok, G. Molema, and G. Storm Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin J. Control. Release 91 2003 115 122
76. G.A. Koning, R.M. Schiffelers, M.H. Wauben, R.J. Kok, E. Mastrobattista, G. Molema, T.L. ten Hagen, and G. Storm Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis Arthritis Rheum. 54 2006 1198 1208
77. C. Grange, M. Tapparo, S. Bruno, D. Chatterjee, P.J. Quesenberry, C. Tetta, and G. Camussi Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging Int. J. Mol. Med. 33 2014 1055 1063
78. X. Zhuang, X. Xiang, W. Grizzle, D. Sun, S. Zhang, R.C. Axtell, S. Ju, J. Mu, L. Zhang, L. Steinman, D. Miller, and H.G. Zhang Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain Mol. Ther. 19 2011 1769 1779
79. B.J. Tauro, D.W. Greening, R.A. Mathias, H. Ji, S. Mathivanan, A.M. Scott, and R.J. Simpson Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes Methods 56 2012 293 304
80. N. Chaput, and C. Thery Exosomes: immune properties and potential clinical implementations Semin. Immunopathol. 33 2011 419 440
81. T. Lammers, F. Kiessling, W.E. Hennink, and G. Storm Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress J. Control. Release 161 2012 175 187
82. T.D. Heath, R.T. Fraley, J. Bentz, E.W. Voss Jr., J.N. Herron, and D. Papahadjopoulos Antibody-directed liposomes. Determination of affinity constants for soluble and liposome-bound antifluorescein Biochim. Biophys. Acta 770 1984 148 158
83. J.W. Park, K. Hong, D.B. Kirpotin, G. Colbern, R. Shalaby, J. Baselga, Y. Shao, U.B. Nielsen, J.D. Marks, D. Moore, D. Papahadjopoulos, and C.C. Benz Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery Clin. Cancer Res. 8 2002 1172 1181
84. E. Koren, and V.P. Torchilin Cell-penetrating peptides: breaking through to the other side Trends Mol. Med. 18 2012 385 393
85. H. Hillaireau, and P. Couvreur Nanocarriers' entry into the cell: relevance to drug delivery Cell. Mol. Life Sci. 66 2009 2873 2896
86. A. Aderem, and D.M. Underhill Mechanisms of phagocytosis in macrophages Annu. Rev. Immunol. 17 1999 593 623
87. K. Denzer, M.J. Kleijmeer, H.F. Heijnen, W. Stoorvogel, and H.J. Geuze Exosome: from internal vesicle of the multivesicular body to intercellular signaling device J. Cell Sci. 113 Pt 19 2000 3365 3374
88. C. Villarroya-Beltri, F. Baixauli, C. Gutierrez-Vazquez, F. Sanchez-Madrid, and M. Mittelbrunn Sorting it out: regulation of exosome loading Semin. Cancer Biol. 2014 http://dc.doi.org/10.1016/j.semcancer.2014.04.009
89. J.C. Akers, D. Gonda, R. Kim, B.S. Carter, and C.C. Chen Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies J. Neurooncol 113 2013 1 11
90. V.A. Fadok, J.S. Savill, C. Haslett, D.L. Bratton, D.E. Doherty, P.A. Campbell, and P.M. Henson Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells J. Immunol. 149 1992 4029 4035
91. J. Savill, and V. Fadok Corpse clearance defines the meaning of cell death Nature 407 2000 784 788
92. J. Savill, I. Dransfield, C. Gregory, and C. Haslett A blast from the past: clearance of apoptotic cells regulates immune responses Nat. Rev. Immunol. 2 2002 965 975
93. R. Hanayama, M. Tanaka, K. Miyasaka, K. Aozasa, M. Koike, Y. Uchiyama, and S. Nagata Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice Science 304 2004 1147 1150
94. M. Simons, and G. Raposo Exosomes - vesicular carriers for intercellular communication Curr. Opin. Cell Biol. 21 2009 575 581
95. C. Thery, M. Ostrowski, and E. Segura Membrane vesicles as conveyors of immune responses Nat. Rev. Immunol. 9 2009 581 593
96. H.C. Christianson, K.J. Svensson, and M. Belting Exosome and microvesicle mediated phene transfer in mammalian cells Semin. Cancer Biol. 2014 10.1016/j.semcancer.2014.04.007
97. K. Al-Nedawi, B. Meehan, J. Micallef, V. Lhotak, L. May, A. Guha, and J. Rak Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells Nat. Cell Biol. 10 2008 619 624
98. D. Feng, W.L. Zhao, Y.Y. Ye, X.C. Bai, R.Q. Liu, L.F. Chang, Q. Zhou, and S.F. Sui Cellular internalization of exosomes occurs through phagocytosis Traffic 11 2010 675 687
99. T. Tian, Y.L. Zhu, F.H. Hu, Y.Y. Wang, N.P. Huang, and Z.D. Xiao Dynamics of exosome internalization and trafficking J. Cell. Physiol. 228 2013 1487 1495
100. T. Tian, Y. Wang, H. Wang, Z. Zhu, and Z. Xiao Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy J. Cell. Biochem. 111 2010 488 496
101. A. Montecalvo, A.T. Larregina, W.J. Shufesky, D.B. Stolz, M.L. Sullivan, J.M. Karlsson, C.J. Baty, G.A. Gibson, G. Erdos, Z. Wang, J. Milosevic, O.A. Tkacheva, S.J. Divito, R. Jordan, J. Lyons-Weiler, S.C. Watkins, and A.E. Morelli Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes Blood 119 2012 756 766
102. D. Fitzner, M. Schnaars, D. van Rossum, G. Krishnamoorthy, P. Dibaj, M. Bakhti, T. Regen, U.K. Hanisch, and M. Simons Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis J. Cell Sci. 124 2011 447 458
103. H.C. Christianson, K.J. Svensson, T.H. van Kuppevelt, J.P. Li, and M. Belting Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity Proc. Natl. Acad. Sci. U. S. A. 110 2013 17380 17385
104. J. Wolfers, A. Lozier, G. Raposo, A. Regnault, C. Thery, C. Masurier, C. Flament, S. Pouzieux, F. Faure, T. Tursz, E. Angevin, S. Amigorena, and L. Zitvogel Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming Nat. Med. 7 2001 297 303
105. A. Montecalvo, W.J. Shufesky, D.B. Stolz, M.G. Sullivan, Z. Wang, S.J. Divito, G.D. Papworth, S.C. Watkins, P.D. Robbins, A.T. Larregina, and A.E. Morelli Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition J. Immunol. 180 2008 3081 3090
106. G. Andreola, L. Rivoltini, C. Castelli, V. Huber, P. Perego, P. Deho, P. Squarcina, P. Accornero, F. Lozupone, L. Lugini, A. Stringaro, A. Molinari, G. Arancia, M. Gentile, G. Parmiani, and S. Fais Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles J. Exp. Med. 195 2002 1303 1316
107. V. Huber, S. Fais, M. Iero, L. Lugini, P. Canese, P. Squarcina, A. Zaccheddu, M. Colone, G. Arancia, M. Gentile, E. Seregni, R. Valenti, G. Ballabio, F. Belli, E. Leo, G. Parmiani, and L. Rivoltini Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape Gastroenterology 128 2005 1796 1804
108. D.D. Taylor, C. Gercel-Taylor, K.S. Lyons, J. Stanson, and T.L. Whiteside T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors Clin. Cancer Res. 9 2003 5113 5119
109. P.R. Cullis, L.D. Mayer, M.B. Bally, T.D. Madden, and M.J. Hope Generating and loading of liposomal systems for drug-delivery applications Adv. Drug Deliv. Rev. 3 1989 267 282
110. J. Gubernator Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity Expert Opin. Drug Deliv. 8 2011 565 580
111. D. Zucker, D. Marcus, Y. Barenholz, and A. Goldblum Liposome drugs' loading efficiency: a working model based on loading conditions and drug's physicochemical properties J. Control. Release 139 2009 73 80
112. D.W. Deamer, R.C. Prince, and A.R. Crofts The response of fluorescent amines to pH gradients across liposome membranes Biochim. Biophys. Acta 274 1972 323 335
113. J.W. Nichols, and D.W. Deamer Catecholamine uptake and concentration by liposomes maintaining p/ gradients Biochim. Biophys. Acta 455 1976 269 271
114. T.D. Madden, P.R. Harrigan, L.C. Tai, M.B. Bally, L.D. Mayer, T.E. Redelmeier, H.C. Loughrey, C.P. Tilcock, L.W. Reinish, and P.R. Cullis The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey Chem. Phys. Lipids 53 1990 37 46
115. A. Cern, Y. Barenholz, A. Tropsha, and A. Goldblum Computer-aided design of liposomal drugs: in silico prediction and experimental validation of drug candidates for liposomal remote loading J. Control. Release 173 2014 125 131
116. G. Haran, R. Cohen, L.K. Bar, and Y. Barenholz Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases Biochim. Biophys. Acta 1151 1993 201 215
117. S. Clerc, and Y. Barenholz Loading of amphipathic weak acids into liposomes in response to transmembrane calcium acetate gradients Biochim. Biophys. Acta 1240 1995 257 265
118. A. Cern, A. Golbraikh, A. Sedykh, A. Tropsha, Y. Barenholz, and A. Goldblum Quantitative structure-property relationship modeling of remote liposome loading of drugs J. Control. Release 160 2012 147 157
119. ® - the first FDA-approved nano-drug: lessons learned J. Control. Release 160 2012 117 134
120. G. Berry, M. Billingham, E. Alderman, P. Richardson, F. Torti, B. Lum, A. Patek, and F.J. Martin The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin Ann. Oncol. 9 1998 711 716
121. D. Lorusso, A. Di Stefano, V. Carone, A. Fagotti, S. Pisconti, and G. Scambia Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome) Ann. Oncol. 18 2007 1159 1164
122. A.J. Templeton, K. Ribi, C. Surber, H. Sun, S.F. Hsu Schmitz, M. Beyeler, D. Dietrich, M. Borner, A. Winkler, A. Müller, L. von Rohr, R.C. Winterhalder, C. Rochlitz, R. von Moos, K. Zaman, B.J.K. Thurlimann, and T. Ruhstaller on behalf of the Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08) Breast 23 2014 244 249
123. J. Lademann, A. Martschick, F. Kluschke, H. Richter, J.W. Fluhr, A. Patzelt, S. Jung, R. Chekerov, M.E. Darvin, N. Haas, W. Sterry, L. Zastrow, and J. Sehouli Efficient prevention strategy against the development of a palmar-plantar erythrodysesthesia during chemotherapy Skin Pharmacol. Physiol. 27 2014 66 70
124. J. Eckes, O. Schmah, J.W. Siebers, U. Groh, S. Zschiedrich, B. Rautenberg, A. Hasenburg, M. Jansen, M.J. Hug, K. Winkler, and G. Putz Kinetic targeting of pegylated liposomal doxorubicin: a new approach to reduce toxicity during chemotherapy (CARL-trial) BMC Cancer 11 2011 337
125. M.D. Moen, K.A. Lyseng-Williamson, and L.J. Scott Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections Drugs 69 2009 361 392
126. I.V. Zhigaltsev, G. Winters, M. Srinivasulu, J. Crawford, M. Wong, L. Amankwa, D. Waterhouse, D. Masin, M. Webb, N. Harasym, L. Heller, M.B. Bally, M.A. Ciufolini, P.R. Cullis, and N. Maurer Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles J. Control. Release 144 2010 332 340
127. S. Sur, A.C. Fries, K.W. Kinzler, S. Zhou, and B. Vogelstein Remote loading of preencapsulated drugs into stealth liposomes Proc. Natl. Acad. Sci. U. S. A. 111 2014 2283 2288
128. D. Zucker, and Y. Barenholz Optimization of vincristine-topotecan combination - paving the way for improved chemotherapy regimens by nanoliposomes J. Control. Release 146 2010 326 333
129. D. Zucker, A.V. Andriyanov, A. Steiner, U. Raviv, and Y. Barenholz Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy J. Control. Release 160 2012 281 289
130. I.M. Shaikh, K.B. Tan, A. Chaudhury, Y. Liu, B.J. Tan, B.M. Tan, and G.N. Chiu Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft J. Control. Release 172 2013 852 861
131. P. Tardi, S. Johnstone, N. Harasym, S. Xie, T. Harasym, N. Zisman, P. Harvie, D. Bermudes, and L. Mayer In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy Leuk. Res. 33 2009 129 139
132. P.G. Tardi, R.C. Gallagher, S. Johnstone, N. Harasym, M. Webb, M.B. Bally, and L.D. Mayer Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo Biochim. Biophys. Acta 1768 2007 678 687
133. A. Fire, S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, and C.C. Mello Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 1998 806 811
134. S.M. Elbashir, W. Lendeckel, and T. Tuschl RNA interference is mediated by 21- and 22-nucleotide RNAs Genes Dev. 15 2001 188 200
135. B.L. Davidson, and P.B. McCray Jr. Current prospects for RNA interference-based therapies Nat. Rev. Genet. 12 2011 329 340
136. A. Daka, and D. Peer RNAi-based nanomedicines for targeted personalized therapy Adv. Drug Deliv. Rev. 64 2012 1508 1521
137. H. Yin, R.L. Kanasty, A.A. Eltoukhy, A.J. Vegas, J.R. Dorkin, and D.G. Anderson Non-viral vectors for gene-based therapy Nat. Rev. Genet. 15 2014 541 555
138. Y.Y. Tam, S. Chen, and P.R. Cullis Advances in lipid nanoparticles for siRNA delivery Pharmaceutics 5 2013 498 507
139. S.C. Semple, T.O. Harasym, K.A. Clow, S.M. Ansell, S.K. Klimuk, and M.J. Hope Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid J. Pharmacol. Exp. Ther. 312 2005 1020 1026
140. S.C. Semple, S.K. Klimuk, T.O. Harasym, N. Dos Santos, S.M. Ansell, K.F. Wong, N. Maurer, H. Stark, P.R. Cullis, M.J. Hope, and P. Scherrer Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures Biochim. Biophys. Acta 1510 2001 152 166
141. N. Maurer, K.F. Wong, H. Stark, L. Louie, D. McIntosh, T. Wong, P. Scherrer, S.C. Semple, and P.R. Cullis Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes Biophys. J. 80 2001 2310 2326
142. I.M. Hafez, N. Maurer, and P.R. Cullis On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids Gene Ther. 8 2001 1188 1196
143. S.C. Semple, A. Akinc, J. Chen, A.P. Sandhu, B.L. Mui, C.K. Cho, D.W. Sah, D. Stebbing, E.J. Crosley, E. Yaworski, I.M. Hafez, J.R. Dorkin, J. Qin, K. Lam, K.G. Rajeev, K.F. Wong, L.B. Jeffs, L. Nechev, M.L. Eisenhardt, M. Jayaraman, M. Kazem, M.A. Maier, M. Srinivasulu, M.J. Weinstein, Q. Chen, R. Alvarez, S.A. Barros, S. De, S.K. Klimuk, T. Borland, V. Kosovrasti, W.L. Cantley, Y.K. Tam, M. Manoharan, M.A. Ciufolini, M.A. Tracy, A. de Fougerolles, I. MacLachlan, P.R. Cullis, T.D. Madden, and M.J. Hope Rational design of cationic lipids for siRNA delivery Nat. Biotechnol. 28 2010 172 176
144. M. Jayaraman, S.M. Ansell, B.L. Mui, Y.K. Tam, J. Chen, X. Du, D. Butler, L. Eltepu, S. Matsuda, J.K. Narayanannair, K.G. Rajeev, I.M. Hafez, A. Akinc, M.A. Maier, M.A. Tracy, P.R. Cullis, T.D. Madden, M. Manoharan, and M.J. Hope Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo Angew. Chem. Int. Ed. Engl. 51 2012 8529 8533
145. K.T. Love, K.P. Mahon, C.G. Levins, K.A. Whitehead, W. Querbes, J.R. Dorkin, J. Qin, W. Cantley, L.L. Qin, T. Racie, M. Frank-Kamenetsky, K.N. Yip, R. Alvarez, D.W. Sah, A. de Fougerolles, K. Fitzgerald, V. Koteliansky, A. Akinc, R. Langer, and D.G. Anderson Lipid-like materials for low-dose, in vivo gene silencing Proc. Natl. Acad. Sci. U. S. A. 107 2010 1864 1869
146. N.M. Belliveau, J. Huft, P.J. Lin, S. Chen, A.K. Leung, T.J. Leaver, A.W. Wild, J.B. Lee, R.J. Taylor, Y.K. Tam, C.L. Hansen, and P.R. Cullis Microfluidic synthesis of highly potent limit-size lipid nanoparticles for in vivo delivery of siRNA Mol. Ther. Nucleic Acids 1 2012 e37
147. I.V. Zhigaltsev, N. Belliveau, I. Hafez, A.K. Leung, J. Huft, C. Hansen, and P.R. Cullis Bottom-up design and synthesis of limit size lipid nanoparticle systems with aqueous and triglyceride cores using millisecond microfluidic mixing Langmuir 28 2012 3633 3640
148. A.K. Leung, I.M. Hafez, S. Baoukina, N.M. Belliveau, I.V. Zhigaltsev, E. Afshinmanesh, D.P. Tieleman, C.L. Hansen, M.J. Hope, and P.R. Cullis Lipid nanoparticles containing siRNA synthesized by microfluidic mixing exhibit an electron-dense nanostructured core J. Phys. Chem. C Nanomater. Interfaces 116 2012 18440 18450
149. D. Haussecker The business of RNAi therapeutics in 2012 Mol. Ther. Nucleic acids 1 2012 e8
150. A. Akinc, W. Querbes, S. De, J. Qin, M. Frank-Kamenetsky, K.N. Jayaprakash, M. Jayaraman, K.G. Rajeev, W.L. Cantley, J.R. Dorkin, J.S. Butler, L. Qin, T. Racie, A. Sprague, E. Fava, A. Zeigerer, M.J. Hope, M. Zerial, D.W. Sah, K. Fitzgerald, M.A. Tracy, M. Manoharan, V. Koteliansky, A. Fougerolles, and M.A. Maier Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms Mol. Ther. 18 2010 1357 1364
151. Y.Y. Tam, S. Chen, J. Zaifman, Y.K. Tam, P.J. Lin, S. Ansell, M. Roberge, M.A. Ciufolini, and P.R. Cullis Small molecule ligands for enhanced intracellular delivery of lipid nanoparticle formulations of siRNA Nanomedicine 9 2013 665 674
152. R. van der Meel, L.J. Vehmeijer, R.J. Kok, G. Storm, and E.V. van Gaal Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status Adv. Drug Deliv. Rev. 65 2013 1284 1298
153. P. Vader, S.A. Kooijmans, S. Stremersch, and K. Raemdonck New considerations in the preparation of nucleic acid-loaded extracellular vesicles Ther. Deliv. 5 2014 105 107
154. D.C. Drummond, O. Meyer, K. Hong, D.B. Kirpotin, and D. Papahadjopoulos Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors Pharmacol. Rev. 51 1999 691 743
155. L. Alvarez-Erviti, Y. Seow, H. Yin, C. Betts, S. Lakhal, and M.J. Wood Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes Nat. Biotechnol. 29 2011 341 345
156. J. Wahlgren, L.K.T. De, M. Brisslert, F. Vaziri Sani, E. Telemo, P. Sunnerhagen, and H. Valadi Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes Nucleic Acids Res. 40 2012 e130
157. J.L. Hood, M.J. Scott, and S.A. Wickline Maximizing exosome colloidal stability following electroporation Anal. Biochem. 448 2014 41 49
158. S.A. Kooijmans, S. Stremersch, K. Braeckmans, S.C. de Smedt, A. Hendrix, M.J. Wood, R.M. Schiffelers, K. Raemdonck, and P. Vader Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles J. Control. Release 172 2013 229 238
159. A. Mizrak, M.F. Bolukbasi, G.B. Ozdener, G.J. Brenner, S. Madlener, E.P. Erkan, T. Strobel, X.O. Breakefield, and O. Saydam Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth Mol. Ther. 21 2013 101 108
160. N. Kosaka, H. Iguchi, Y. Yoshioka, F. Takeshita, Y. Matsuki, and T. Ochiya Secretory mechanisms and intercellular transfer of microRNAs in living cells J. Biol. Chem. 285 2010 17442 17452
161. Y. Zhang, D. Liu, X. Chen, J. Li, L. Li, Z. Bian, F. Sun, J. Lu, Y. Yin, X. Cai, Q. Sun, K. Wang, Y. Ba, Q. Wang, D. Wang, J. Yang, P. Liu, T. Xu, Q. Yan, J. Zhang, K. Zen, and C.Y. Zhang Secreted monocytic miR-150 enhances targeted endothelial cell migration Mol. Cell 39 2010 133 144
162. M. Katakowski, B. Buller, X. Zheng, Y. Lu, T. Rogers, O. Osobamiro, W. Shu, F. Jiang, and M. Chopp Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth Cancer Lett. 335 2013 201 204
163. K. Tang, Y. Zhang, H. Zhang, P. Xu, J. Liu, J. Ma, M. Lv, D. Li, F. Katirai, G.X. Shen, G. Zhang, Z.H. Feng, D. Ye, and B. Huang Delivery of chemotherapeutic drugs in tumour cell-derived microparticles Nat. Commun. 3 2012 1282
164. Huazhong University of Science and Technology Safety and effectiveness study of tumor cell-derived microparticles to treat malignant ascites and pleural effusion ClinicalTrials.gov [Internet] 2013 National Library of Medicine (US) Bethesda (MD) (Retrieved July 2014, Available from https://clinicaltrials.gov/ct2/show/NCT01854866, NLM Identifier: NCT01854866)
165. M.F. Bolukbasi, A. Mizrak, G.B. Ozdener, S. Madlener, T. Strobel, E.P. Erkan, J.B. Fan, X.O. Breakefield, and O. Saydam miR-1289 and "Zipcode"-like sequence enrich mRNAs in microvesicles Mol. Ther. Nucleic Acids 1 2012 e10
166. C. Villarroya-Beltri, C. Gutierrez-Vazquez, F. Sanchez-Cabo, D. Perez-Hernandez, J. Vazquez, N. Martin-Cofreces, D.J. Martinez-Herrera, A. Pascual-Montano, M. Mittelbrunn, and F. Sanchez-Madrid Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs Nat. Commun. 4 2013 2980
167. T. Katsuda, N. Kosaka, F. Takeshita, and T. Ochiya The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles Proteomics 13 2013 1637 1653